<DOC>
	<DOC>NCT01682525</DOC>
	<brief_summary>To provide a novel fertility preservation option for patients facing a fertility threatening cancer diagnosis or treatment regimen by establishing an ovarian tissue cryopreservation program. To determine if ovarian tissue cryopreservation provides women with a useful, successful option for fertility preservation The hypothesis is that ovarian tissue cryopreservation for fertility preservation provides an alternative option for fertility preservation.</brief_summary>
	<brief_title>Ovarian Tissue Cryopreservation for Fertility Preservation</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<criteria>Will undergo surgery, chemotherapy, drug treatment and/or radiation for the treatment or prevention of a medical condition or malignancy which are likely to result in permanent loss of subsequent ovarian function or diminished fertility Have a medical condition or malignancy that requires removal of all or part of one or both ovaries Patients may have newly diagnosed or recurrent disease Be in good health so as to be able to undergo laparoscopic surgery as determined by history and physical examinations, and consultation with the medical oncologist, reproductive endocrinologist, surgeon and anesthesiologist Moderate to highrisk of ovarian failure due to treatment Documented ovarian metastasis HIV or hepatitis (B, C)positive serology Absolute surgical contraindications ECOG performance status of 0 or 1 Pregnancy Women with psychological, psychiatric, or other conditions which prevent giving fully informed consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Fertility preservation</keyword>
	<keyword>Ovarian Tissue</keyword>
	<keyword>Cryopreservation</keyword>
	<keyword>Assisted Reproductive Technology</keyword>
</DOC>